Change Language

Select Language

North America DNA Sequencing Products Market to Reach US$ 5.2 Billion by 2027, Spurred by Growing Preference for Personalized Medicines

Published on Sep 07, 2020

According to the latest report by IMARC Group, titled "North America DNA Sequencing Products Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the North America DNA sequencing products market reached a value of US$ 2.2 Billion in 2021. DNA sequencing refers to the process of understanding the accurate sequence of the four nucleotide bases, namely guanine, thymine, adenine and cytosine, present within a DNA molecule. It is widely used for mapping out the human genome and for various applied research applications. It is crucial in determining multiple nucleotide variations related to distinctive genetic diseases, thereby aiding in the study of several complex disorders. Apart from this, it is extensively used for numerous research studies and applications, such as genome editing, forensic sciences, agrigenomics, species discovery, DNA recombination, hereditary disease detection, and phylogenetic analysis.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

North America DNA Sequencing Products Market Trends:

The North American market is primarily driven by the growing utilization of DNA sequencing products in in-vitro diagnostics. These diagnostics are used to detect multiple diseases and monitor a person’s overall health for curing and preventing several medical conditions. Since next-generation sequencing tests are usually performed to scan a person’s DNA for detecting genomic variations, this is providing a thrust to the market growth. The growing preference for personalized medicines and targeted therapies among patients is acting as a major growth-inducing factor. DNA sequencing provides information about the genetic basis of several diseases. This aids in the development of precise treatments to affect the pathogens in the body without damaging healthy cells. The market is further driven by the increasing initiatives undertaken by several industry players in the region to facilitate the development of new and affordable technologies. For instance, the National Human Genome Research Institute (NHGRI), a US-based institute and a part of the National Institutes of Health (NIH), offers grants in developing cost-effective DNA sequencing with the use of nanoscale technologies. Numerous companies are also engaging to develop alternative sequencing technologies that offer improved yield, speed and sensitivity, thereby creating a positive outlook for the market. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 5.2 Billion by 2027, exhibiting a CAGR of 15.4% during 2022-2027.

Market Summary:

  • Based on the product type, the market has been divided into consumables and reagents, and equipments.
  • On the basis of the application, the market has been classified into biomarkers, diagnostics, reproductive health, forensics, personalized medicine and others.
  • Based on the end user, the market has been categorized into academic and government research institutes, pharmaceutical and biotechnology companies, hospitals and clinics, and others.
  • On the geographical front, the market has been bifurcated into the United States and Canada.
  • The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800


Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91-120-433-0800 )

Drop us an email at